Medication info

Alphos Tablets

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletSucralfate Hydrate›300mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tablet
Manufacturer / importer
OS Korea Pharmaceutical Co., Ltd.
Appearance
Green round film-coated tablets
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Expired

MFDS item code 201902049 · Approved 2019.04.04

This product's status changed to Expired on 2024.04.04. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of gastrointestinal disorders (including ulcers, gastritis, and gastroesophageal reflux disease); prevention of Mendelson syndrome
Who takes it
Adults
Adult dose
Usually, take 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by taking 4 tablets twice daily, in the morning and at bedtime. The dose is the same for ulcers caused by administration of nonsteroidal anti-inflammatory drugs (NSAIDs) or for concomitant therapy to prevent gastric and duodenal ulcers during long-term NSAID administration. Diseases caused by NSAID administration usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, take 2 tablets twice daily or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times daily and increase the dose as necessary. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets on the night before surgery.

Ingredients

Manufacturer
OS Korea Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastrointestinal disorders (including ulcers, gastritis, and gastroesophageal reflux disease); prevention of Mendelson syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
  • NSAID-induced gastric and duodenal ulcers
View approved original text

This medication is used for gastrointestinal diseases such as gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also administered to prevent Mendelson's syndrome before anesthesia and is used for treating ulcers resulting from surgeries or those caused by non-steroidal anti-inflammatory drugs (NSAIDs). It helps in treating a variety of gastric-related conditions and improves symptoms.

How to take

Adult dose

Usually, take 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by taking 4 tablets twice daily, in the morning and at bedtime. The dose is the same for ulcers caused by administration of nonsteroidal anti-inflammatory drugs (NSAIDs) or for concomitant therapy to prevent gastric and duodenal ulcers during long-term NSAID administration. Diseases caused by NSAID administration usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, take 2 tablets twice daily or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times daily and increase the dose as necessary. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets on the night before surgery.

Precautions

This drug should not be used in patients with severely impaired kidney function or those undergoing dialysis. It should also not be administered to patients who have a history of allergy to this drug or its components. Patients with a history of acute porphyria, a rare blood disorder, may experience seizures and should not receive this medication. It is contraindicated in patients with kidney impairment, those who have undergone gastrointestinal surgery, pregnant or potentially pregnant women, and premature or newborn infants. Additionally, it should be avoided in patients who need to restrict potassium intake. Caution is advised in patients with impaired liver function, patients with a previous history of drug allergies, elderly patients, and patients with a history of kidney problems. Patients taking NSAIDs, especially elderly patients or those with a history of peptic ulcers, should have their condition monitored regularly. This medication can mask symptoms of gastric cancer, so patients with gastric ulcers or those who have recently developed or changed dyspeptic symptoms above middle age should confirm that it is not a malignancy before administration. Patients with Helicobacter pylori-induced gastric and duodenal ulcers require treatment to eradicate the bacterium. In critically ill patients, this medication may cause the formation of bezoars after administration; caution is needed. Patients with hypophosphatemia should be careful as the aluminum component of this drug may interfere with phosphate absorption. In patients who have difficulty swallowing, respiratory complications have been reported after taking this medication, so it should be used cautiously. Rarely, during treatment with this medication, serious allergic reactions, such as anaphylactic shock, can occur; if symptoms appear, administration should be stopped immediately and treated. Allergic symptoms such as skin rash, hives, angioedema, fever, bronchospasm, hypotension, and chest pain may also occur infrequently, and if these symptoms appear, medication should be discontinued. Blood tests may reveal abnormalities, including leukopenia and thrombocytopenia; if systemic malaise, weakness, bleeding, or fever occurs, urgent testing is recommended, and the medication should be discontinued if necessary. Impaired liver function may occur; therefore, if jaundice or symptoms of hepatitis are apparent, the medication should be discontinued. Rare cases of cardiac arrhythmia or vasculitis have been reported, so attention to cardiovascular symptoms is essential. Gastrointestinal symptoms may include nausea, vomiting, constipation, diarrhea, and abdominal pain; stool color may change, but treatment is not required. Severe symptoms such as dizziness, drowsiness, confusion, seizures, insomnia, headache, hallucinations, and neurological symptoms may occur, particularly in severe and elderly patients. Myalgia or arthralgia may occur rarely, and if severe muscle damage symptoms appear, medication should be stopped immediately. Skin rash, hair loss, and pruritus may occur infrequently. It is advisable not to use this medication continuously for long periods; if there is no therapeutic effect, a change to another medication should be considered. Elderly patients, those with chronic pulmonary diseases, diabetes, and immunocompromised individuals may have an increased risk of pneumonia following this medication, necessitating caution. If dizziness or drowsiness occurs during treatment, driving or operation of hazardous machinery should be avoided. This medication may interact with other drugs, so consultation with a physician or pharmacist is necessary, particularly when taken with anticoagulants, antibiotics, or anticonvulsants. It is safest for pregnant or potentially pregnant women, as well as nursing mothers, not to use this medication. Safety and efficacy have not been adequately established for children; thus, it is preferable not to give it to them. In cases of overdose, emergency treatment such as vomiting or gastric lavage may be necessary, and hemodialysis can be performed to eliminate the drug. This medication can decrease gastric acid secretion and promote bacterial growth in the gastrointestinal tract; therefore, ocular examinations may be needed during long-term use.

Side effects

  • Anaphylactic shock
  • skin rash
  • hives
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 57 more
  • thrombocytopenia
  • elevated serum creatinine
  • elevated serum aminotransferase
  • agranulocytosis
  • pancytopenia
  • myelodysplasia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • elevated AST
  • elevated ALT
  • elevated r-GTP
  • elevated ALP
  • jaundiced hepatitis
  • non-jaundiced hepatitis
  • tachycardia
  • bradycardia
  • atrioventricular block
  • premature ventricular contraction
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • cramps
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • illness sense
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • consciousness disturbances
  • hypertrophic muscle spasms
  • gynecomastia
  • excessive milk secretion
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • mild erythema multiforme
  • alopecia
  • glossitis
  • skin itching
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air exposure, ideally at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the drug's effectiveness and ensures safe usage.

Appearance and packaging

Appearance

Green round film-coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.